Drugs for Withdrawal Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 156)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acetylcholine |
Approved, Investigational |
Phase 4 |
|
51-84-3 |
187 |
Synonyms:
[2-(ACETYLOXY)ETHYL]TRIMETHYLAZANIUM
2-(Acetyloxy)-N,N,N-trimethylethanaminium
2-ACETOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AMMONIUM
2-ACETYLOXYETHYL(TRIMETHYL)AZANIUM
Acetilcolina cusi
Acetyl choline ion
Acetylcholine
Acetylcholine bromide
Acetylcholine cation
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
ACETYLCHOLINE, ACH
Acetylcholinium: acetyl-choline
|
ACh
ACh|E1001|O-acetylcholine
Alcon brand OF acetylcholine chloride
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
E1001
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
2 |
|
Lofexidine |
Approved, Investigational |
Phase 4 |
|
31036-80-3 |
30668 |
Synonyms:
2-(1-(2,6-Dichlorophenoxy)ethyl)-4,5-dihydro-1H-imidazole
2-(a-(2,6-Dichlorophenoxy)ethyl)2-imidazoline
2-(alpha-(2,6-Dichlorophenoxy)ethyl) delta-2-imidazoline
2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline
2-(Α-(2,6-dichlorophenoxy)ethyl)2-imidazoline
BritLofex
BritLofex®|Lucemyra®
Lofexidina
|
Lofexidina [inn-spanish]
Lofexidine
Lofexidine hydrochloride
Lofexidine monohydrochloride
Lofexidine mono-hydrochloride
Lofexidine, (+-)-isomer
Lofexidinum
Lofexidinum [inn-latin]
|
|
3 |
|
Valproic acid |
Approved, Investigational |
Phase 4 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 Propylpentanoic acid
2-N-PROPYL-4-PENTENOIC ACID
2-N-Propyl-N-valerate
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-Propylpentanoic acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-Propylvaleric acid
44089
4-Heptanecarboxylate
4-Heptanecarboxylic acid
A-44090
A-44090|Depakote®|Epilim®|valproate sodium
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acido valproico
ácido valproico
Acidum valproicum
Alti-valproic
Apo-divalproex
Apo-valproic
Apo-valproic syrup
Avugane
Baceca
Calcium valproate
Calcium, valproate
Convulex
Convulsofin
Delepsine
Depacon
Depakene
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Deproic
Di-N-propylacetate
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-n-propylessigsäure
Dipropyl acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DOM-divalproex
Dom-valproate
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
Epiject i.v.
Epilex
Epilim
|
Epival
Epival er
Ergenyl
Gen-divalproex
Kyselina 2-propylvalerova
LEP321
Magnesium valproate
Med valproic
Mylproin
Myproate
Myproic acid
N-Dipropylacetic acid
N-DPA
Novo-divalproex
Novo-valproic
Novo-valproic - ecc
Novo-valproic soft gel cap
NSC-93819
Nu-valproic
PEAC
Penta-valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
Ratio-valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
Sandoz valproic
Savicol
Semisodium valproate
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
Sprinkle
STAVZOR
Valcote
Valparin
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
VALPROIC ACID
Valproic acid usp
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
|
|
4 |
|
Gabapentin |
Approved, Investigational |
Phase 4 |
|
60142-96-3 |
3446 |
Synonyms:
1-(Aminomethyl)cyclohexaneacetate
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
Aclonium
Apo gabapentin
Apo-gabapentin
ApoGabapentin
CI 945
CI 945|Go 3450|GOE 2450|GOE 3450|Neurontin®
CI-945
Convalis
DM-1796
GABAPENTIN
GABAPENTIN GR
Gabapentin hexal
Gabapentin ratiopharm
Gabapentin stada
Gabapentina
Gabapentine
|
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentin-ratiopharm
Gabapentinum
Gabapentinum [INN-Latin]
Gabapetin
GO 3450
GOE 2450
GOE 3450
GOE-3450
Gralise
Neurontin
Novo gabapentin
Novo-gabapentin
NovoGabapentin
Novo-gabapentine
PMS-Gabapentin
|
|
5 |
|
Venlafaxine |
Approved |
Phase 4 |
|
99300-78-4, 93413-69-5 |
5656 |
Synonyms:
1-(2-(dimethylamino)-1-(4-Methoxyphenyl)ethyl)cyclohexanol HCL
1-[2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL]CYCLOHEXAN-1-OL
ALVENTA XL
AMPHERO XL
BONILUX XL
Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
DEPEFEX XL
Dobupal
Efectin
Efexor
EFEXOR XL
Effexor
EFFEXOR XR
Effexor®|WY-45030
Elafax
FORAVEN XL
Hydrochloride, venlafaxine
MENTAVEN XL
POLITID XL
RANFAXINE XL
RODOMEL XL
Sila venlafaxine
Sila-venlafaxine
SUNVENIZ XL
TARDCAPS XL
TIFAXIN XL
|
TONPULAR XL
Trevilor
TRIXAT XL
Vandral
VAXALIN XL
VENAXX XL
VENLABLUE XL
VENLADEX XL
Venlafaxin
Venlafaxina
Venlafaxina [INN-Spanish]
VENLAFAXINE
Venlafaxine [INN:Ban]
VENLAFAXINE HCL
Venlafaxine hydrochloride
Venlafaxinum
Venlafaxinum [INN-Latin]
Venlafexine
VENLALIC XL
VENLANEO XL
VENSIR XL
VEXARIN XL
VIEPAX
VIEPAX XL
WINFEX XL
WY-45030
|
|
6 |
|
Tramadol |
Approved, Investigational |
Phase 4 |
|
27203-92-5 |
33741 5523 |
Synonyms:
(+)-Tramadol
(+)-trans-2-(Dimethylaminomethyl)-1-(m-methoxyphenyl)cyclohexanol
(1RS,2RS)-2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)-CYCLO-HEXANOL
(1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol|Maxitram®|Tilodol®|Tramacet®
1a Brand OF tramadol hydrochloride
AbZ brand OF tramadol hydrochloride
Acis brand OF tramadol hydrochloride
Adolonta
Aliud brand OF tramadol hydrochloride
Allphar brand OF tramadol hydrochloride
Alpharma brand OF tramadol hydrochloride
Amadol
Amanda
Antigen brand OF tramadol hydrochloride
ASTA medica brand OF tramadol hydrochloride
Azupharma brand OF tramadol hydrochloride
Basics brand OF tramadol hydrochloride
Bayvit brand OF tramadol hydrochloride
Betapharm brand OF tramadol hydrochloride
Bexal brand OF tramadol hydrochloride
Biocodex brand OF tramadol hydrochloride
Biodalgic
Biokanol
Byk brand OF tramadol hydrochloride
Christiaens brand OF tramadol hydrochloride
Ciclum brand OF tramadol hydrochloride
Cinfa brand OF tramadol hydrochloride
Clonmel brand OF tramadol hydrochloride
Contramal
Crispin
CSL Brand OF tramadol hydrochloride
Docpharm brand OF tramadol hydrochloride
Dolorgiet brand OF tramadol hydrochloride
Edigen brand OF tramadol hydrochloride
Elerte brand OF tramadol hydrochloride
Erempharma brand OF tramadol hydrochloride
ETS6103
ETS-6103
Expanscience brand OF tramadol hydrochloride
Grunenthal brand OF tramadol hydrochloride
Hameln brand OF tramadol hydrochloride
Heumann brand OF tramadol hydrochloride
Hexal brand OF tramadol hydrochloride
Janssen brand OF tramadol hydrochloride
Juta brand OF tramadol hydrochloride
Jutadol
Kade brand OF tramadol hydrochloride
Kern brand OF tramadol hydrochloride
Knoll brand OF tramadol hydrochloride
Krewel brand OF tramadol hydrochloride
Lakeside brand OF tramadol hydrochloride
Lichtenstein brand OF tramadol hydrochloride
Lindopharm brand OF tramadol hydrochloride
Mabo brand OF tramadol hydrochloride
MAXITRAM
Medix brand OF tramadol hydrochloride
Merck dura brand OF tramadol hydrochloride
MTW Brand OF tramadol hydrochloride
MTW Tramadol
MTWTramadol
MTW-Tramadol
Mundipharma brand OF tramadol hydrochloride
Nobligan
Normon brand OF tramadol hydrochloride
Ortho brand OF tramadol hydrochloride
Prontofort
Q Pharm brand OF tramadol hydrochloride
Q-Pharm brand OF tramadol hydrochloride
Ralivia ER
Ralivia Flashtab
Ranitidin 1a pharma
Ratiopharm brand OF tramadol hydrochloride
Rowa brand OF tramadol hydrochloride
Searle brand OF tramadol hydrochloride
Stadapharm brand OF tramadol hydrochloride
TAD brand OF tramadol hydrochloride
|
Takadol
Theradol
Theraplix brand OF tramadol hydrochloride
TILODOL
Tiral
Topalgic
Tradol
Tradol puren
Tradol-puren
TradolPuren
Tradonal
Tralgiol
Trama 1a pharma
Trama abz
Trama dorsch
Trama KD
Tramabeta
TRAMACET
Tramadin
Tramadoc
Tramadol
Tramadol 1a
Tramadol acis
Tramadol al
Tramadol asta medica
Tramadol basics
Tramadol bayvit
Tramadol bexal
Tramadol cinfa
Tramadol dolgit
Tramadol edigen
Tramadol hameln
Tramadol HCl
Tramadol HCl BP/EP
Tramadol heumann
Tramadol hydrochloride
Tramadol kern
Tramadol lichtenstein
Tramadol lindo
Tramadol mabo
Tramadol normon
Tramadol PB
Tramadol ratiopharm
Tramadol stada
Tramadol viatris brand
Tramadol-dolgit
TramadolDolgit
Tramadol-hameln
TramadolHameln
Tramadolor
Tramadolratiopharm
Tramadol-ratiopharm
Tramadolum
Tramadolum [INN-Latin]
Trama-dorsch
TramaDorsch
Tramadura
Tramagetic
Tramagit
Tramake
Tramal
Tramex
Tramodol Hcl
Tramundin
Trasedal
Tridural
ULTRACET
Ultram
Ultram ER
Viatris brand OF tramadol
Xymel 50
Zambon brand OF tramadol hydrochloride
Zamudol
Zumalgic
Zydol
Zytram
|
|
7 |
|
Norepinephrine |
Approved |
Phase 4 |
|
51-41-2 |
439260 |
Synonyms:
(-)-(R)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(−)-arterenol
(-)-Arterenol
(−)-noradrenaline
(-)-Noradrenaline
(−)-norepinephrine
(-)-Norepinephrine
(-)-norepinephrine|Levarterenol®|noradrenaline
(R)-(−)-norepinephrine
(R)-(-)-Norepinephrine
(R)-4-(2-amino-1-hydroxyethyl)-1,2-benzenediol
(R)-noradrenaline
(R)-norepinephrine
4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-AMINO-1-HYDROXYETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]BENZENE-1,2-DIOL
4-[(1R)-2-AMINO-1-HYDROXY-ETHYL]PYROCATECHOL
Adrenor
Aktamin
Arterenol
L-2-amino-1-(3,4-Dihydroxyphenyl)ethanol
|
L-3,4-Dihydroxyphenylethanolamine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-Arterenol
Levarterenol
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
L-noradrenaline
L-Norepinephrine
Noradrenalin
Noradrenaline
Nor-adrenaline
Norartrinal
Norepinefrina
Norepinephrine
Norépinéphrine
Norepinephrinum
Norepirenamine
Nor-epirenan
R-NOREPINEPHRINE
Sympathin E
|
|
8 |
|
Sodium oxybate |
Approved |
Phase 4 |
|
502-85-2 |
23663870 |
Synonyms:
.GAMMA.-HYDROXYBUTYRATE SODIUM SALT
NSC-84223
OXYBATE SODIUM
SODIUM OXYBATE
|
SODIUM OXYBUTYRATE
WY-3478
XYREM
|
|
9 |
|
Oxazepam |
Approved |
Phase 4 |
|
604-75-1 |
4616 |
Synonyms:
(+-)-Oxazepam
(RS)-Oxazepam
3-Hydroxynordiazepam
Adumbran
Ansioxacepam
Anxiolit
Aplakil
Astress
Azutranquil
Bonare
d-Oxazepam hemisuccinate
Drimuel
Droxacepam
Durazepam
Enidrel
Hi-Long
Isodin
J3.308A
LEDERPAM
Limbial
Murelax
Nesontil
Noctazepam
Nortemazepam
Notaral
NSC-169448
Oxanid
Oxa-puren
OXAZEPAM
OXAZEPAM CIV
|
Oxazipam
Oxozepam
Pacienx
Praxiten
Propax
Psiquiwas
QUEN
Quilibrex
Rondar
Sedigoa
Serax
Serenal
Serenid
SERENID FTE
Serenid-D
Serepax
Seresta
Serpax
Sigacalm
Sobril
Tacepam
Tazepam
TEMAZEPAM IMPURITY, OXAZEPAM-
Uskan
Vaben
WY-3498
Wy-3498 stic
WY-3498oxozepam
ZAXOPAM
|
|
10 |
|
Diazepam |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
439-14-5 |
3016 |
Synonyms:
7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one
Alboral
Aliseum
Alupram
ALUPRAM 10
ALUPRAM 2
ALUPRAM 5
Amiprol
An-Ding
Ansiolin
Ansiolisina
Apaurin
Apo-Diazepam
APOZEPAM
Armonil
Assival
ATENSINE
Atilen
Bensedin
Bialzepam
Calmocitene
Calmpose
Cercine
Ceregulart
DAP
Diacepan
Dialag
DIALAR
DIALAR FTE
Diapam
Diastat
DIASTAT ACUDIAL
Diastat®|LA-III|Valium®|WY-3467
Diazemuls
Diazemulus
Diazepam
DIAZEPAM CIV
DIAZEPAM INTENSOL
Diazepan
Diazetard
Dienpax
Dipam
Dipezona
DIZAC
Domalium
Duksen
Duxen
E-PAM
Eridan
Eurosan
Evacalm
Faustan
Faustan,
Freudal
Frustan
Gewacalm
Gihitan
Kabivitrum
Kiatrium
LA III
LA-III
Lamra
Lembrol
Levium
Liberetas
Mandrozep
Methyl diazepinone
Methyldiazepinone
Morosan
|
Neurolytril
Noan
Novazam
Novo-Dipam
NRL-1
NSC-169897
NSC-77518
Paceum
Pacitran
Paranten
Paxate
PAXEL
Plidan
Pms-Diazepam
Pro-Pam
Q-PAM
Q-Pam Relanium
Quetinil
Quiatril
Quievita
Relaminal
Relanium
Renborin
RO-52807
RO-5-2807
Ruhsitus
Saromet
SCRIPTOPAM
Sedapam
Sedipam
Seduksen
Seduxen
SERENACK
Serenamin
Serenzin
Servizepam
Setonil
Sibazon
Sibazone
SOLIS
Sonacon
Stesolid
Stesolin
TENSIUM
Tensopam
TRANIMUL
Tranqdyn
Tranquase
Tranquirit
Tranquo-Puren
Tranquo-Tablinen
Umbrium
Unisedil
Usempax Ap
Valaxona
VALCLAIR
Valeo
Valiquid
Valitran
Valium
VALRELEASE
Vatran
Velium
Vival
VIVOL
WY-3467
Zetran
Zipan
|
|
11 |
|
Loperamide |
Approved |
Phase 4 |
|
53179-11-6 |
3955 |
Synonyms:
Apo-loperamide
Diamide
FORTASEC
Fortasec®|Imodium®|R-18553
Hydrochloride, loperamide
Imodium
Imodium a-D
Imodium a-D caplets
Kaopectate II
Loperacap
Loperamid
Loperamida
|
Loperamide
Lopéramide
Loperamide hydrochloride
Loperamide monohydrochloride
Loperamidum
Maalox anti-diarrheal
Monohydrochloride, loperamide
Nu-loperamide
PMS-Loperamide
R-18553
Rho-loperamide
|
|
12 |
|
Ketorolac |
Approved |
Phase 4 |
|
74103-06-3, 66635-83-4 |
3826 |
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
ACULAR
Acular LS
Acular Preservative Free
Acular®|Toradol®
Ketoralac
Ketorolac
|
Kétorolac
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
rac-Ketorolac
Toradol
|
|
13 |
|
Metoclopramide |
Approved, Investigational |
Phase 4 |
|
364-62-5 |
4168 |
Synonyms:
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
4-Amino-5-chloro-2-methoxy-N-(b-diethylaminoethyl)benzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-2-methoxy-N-(β-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-O-anisamide
4-AMINO-5-CHLORO-N-(2-DIETHYLAMINOETHYL)-2-METHOXYBENZAMIDE
4-AMINO-5-CHLORO-N-(2-DIETHYLAMINOETHYL)-2-METHOXY-BENZAMIDE
4-AZANYL-5-CHLORANYL-N-(2-DIETHYLAMINOETHYL)-2-METHOXY-BENZAMIDE
Apo-Metoclop
Berk brand OF metoclopramide hydrochloride
Cerucal
CLOPRA
CLOPRA-"YELLOW"
Clopra-Yellow
Clopromate
DEL
Dihydrochloride, metoclopramide
Duraclamid
Elieten
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
Gastro-Timelets
Gimoti® (metoclopramide nasal spray)|metaclopromide|methochlopramide|metochlopramide|metoclopramide hydrochloride|Reglan®
Hydrochloride, metoclopramide
Imperan
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
|
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
METOCLOPRAMIDE
Metoclopramide dihydrochloride
Metoclopramide Hcl
Metoclopramide hydrochloride
Metoclopramide Intensol
Metoclopramide monohydrochloride
Metoclopramide monohydrochloride, monohydrate
Metoclopramide Omega
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
Monohydrochloride, metoclopramide
Moriperan
Mygdalon
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Primperan
Reclomide
Reglan
Reliveran
Rimetin
Temmler brand OF metoclopramide hydrochloride
Terperan
|
|
14 |
|
Varenicline |
Approved, Investigational |
Phase 4 |
|
249296-44-4 |
5310966 |
Synonyms:
6,7,8,9-Tetrahydro-6,10-methano-6H-pyrazino(2,3-H)benzazepine
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-H)(3)benzazepine
Champix
Champix®|Chantix®|compound 9a [PMID: 16171993]|CP 526555
Chantix
CP-526,555
|
CP-526555
Tartrate, varenicline
Vareniclina
VARENICLINE
Varenicline tartrate
Vareniclinum
|
|
15 |
|
Haloperidol |
Approved |
Phase 4 |
|
52-86-8 |
3559 |
Synonyms:
1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine
4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
ALDO
Aloperidin
Aloperidol
Aloperidolo
Aloperidon
Apo-Haloperidol
Bioperidolo
Brotopon
DOLPIN
DOZIC
Dozix
Einalon S
Eukystol
FORTUNAN
g-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
Galoperidol
gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
Haldol
Haldol Decanoate
Haldol La
HALDOL SOLUTAB
Haldol®|MCN-JR-1625|R-1625|Serenace®
Halidol
Halojust
Halol
Halopal
Haloperido
Haloperidol
|
Haloperidol Decanoate
Haloperidol Intensol
Haloperidol Lactate
Haloperidolum
Halopidol
Halopoidol
Halosten
KENTACE
Keselan
KESELEN
Lealgin Compositum
Linton
MCN-JR-1625
Mixidol
Novo-Peridol
NSC-170973
NSC-615296
Pekuces
Peluces
Peridol
Pernox
Pms Haloperidol
R-1625
SERENACE
Serenase
Serenelfi
Sernas
Sernel
Sigaperidol
Ulcolind
Uliolind
Vesalium
Γ-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
|
|
16 |
|
Methimazole |
Approved |
Phase 4 |
|
60-56-0 |
1349907 |
Synonyms:
1 Methyl 2 mercaptoimidazole
1-METHYL-1,3-dihydro-2H-imidazole-2-thione
1-Methyl-2-mercaptoimidazole
1-Methylimidazole-2(3H)-thione
Basolan
Danantizol
Eli lilly brand OF methimazole
Estedi brand OF methimazole
Favistan
Frentirox
Henning berlin brand OF methimazole
Henning, thiamazol
Hexal brand OF methimazole
Hexal, thiamazol
Jones brand OF methimazole
Mercaptazole
Mercasolyl
Mercazol
Mercazole
Mercazolyl
Merck brand OF methimazole
Merkastan
Merkazolil
Metazolo
Methamazole
Methiamazole
Methimazol
METHIMAZOLE
Methizol
Methylmercaptoimidazole
Methymazol
|
Metisol
Metizol
Metothyrin
Metothyrine
Metotirin
Nourypharma brand OF methimazole
NSC-38608
Philopharm brand OF methimazole
Sanofi synthelabo brand OF methimazole
Strumazol
Strumazole
Tapazole
Tapazole®|Thiamazole®
Tapuzole
Temmler brand OF methimazole
Thacapzol
Thiamazol
Thiamazol henning
Thiamazol hexal
Thiamazole
Thiamazolum
Thimazol
Thimazole
Thycapsol
Thycapzol
Thymidazol
Thymidazole
Thyrozol
Tiamazol
Tirodril
USAF el-30
|
|
17 |
|
Clonidine |
Approved |
Phase 4 |
|
4205-91-8, 4205-90-7 |
2803 20179 |
Synonyms:
2-((2,6-Dichlorophenyl)imino)imidazolidine
2,6-Dichloro-N-2-imidazolidinylidenebenzenamine
2-[(2,6-Dichlorophenyl)imino]imidazoline
Adesipress
Boehringer ingelheim brand OF clonidine hydrochloride
Catapres
CATAPRES P.L.
CATAPRES TTS 1
CATAPRES TTS 2
CATAPRES TTS 3
Catapres®|Kapvay®
Catapresan
Catapressan
Catapres-TTS
CATAPRES-TTS-1
CATAPRES-TTS-2
CATAPRES-TTS-3
Catarpres
Catarpresan
Catarpres-TTS
Chlofazoline
Chlophazolin
Chlornidinum
Clofelin
Clofenil
Clonidin
Clonidina
Clonidine
Clonidine dihydrochloride
CLONIDINE HCL
Clonidine hydrochloride
|
Clonidine monohydrobromide
Clonidine monohydrochloride
Clonidinhydrochlorid
Clonidinum
Clonidinum [INN-Latin]
Clonistada
Clopheline
CLORPRES
COMBIPRES
DICHLORANILINO IMIDAZOLIN
Dihydrochloride, clonidine
Dixarit
DURACLON
Duraclont
Gemiton
Hemiton
Hydrochloride, clonidine
Ipotensium
Isoglaucon
JENLOGA
KAPVAY
KAPVAY®
Klofelin
Klofenil
Monohydrobromide, clonidine
Monohydrochloride, clonidine
ST 155BS
ST-155
ST-155BS
ST-155-BS
Tenso-Timelets
|
|
18 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
19 |
|
Pregabalin |
Approved, Investigational |
Phase 4 |
|
148553-50-8 |
5486971 |
Synonyms:
(R-)-3-Isobutyl gaba
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S)-PREGABALIN
(S+)-3-isobutyl gaba
3 Isobutyl gaba
3-(Aminomethyl)-5-methylhexanoic acid
3-Isobutyl gaba
ALZAIN
AXALID
CI 1008
CI-1008
|
GABA, 3-isobutyl
LECAENT
Lyrica
LYRICA CR
NERVALIN
PD 144723
PD-144723
PREGABALIN
Pregabalina
REWISCA
S-(+)-3-ISOBUTYLGABA
YNP-1807
|
|
20 |
|
Glutamic acid |
Approved, Nutraceutical |
Phase 4 |
|
56-86-0 |
33032 |
Synonyms:
(+)-Estrone
(1S)-2-[(3-O-b-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoate
(1S)-2-[(3-O-b-D-Glucopyranosyl-b-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(1S)-2-[(3-O-beta-D-Glucopyranosyl-beta-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(1S)-2-[(3-O-Β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoate
(1S)-2-[(3-O-Β-D-glucopyranosyl-β-D-galactopyranosyl)oxy]-1-{[(9E)-octadec-9-enoyloxy]methyl}ethyl (10E)-nonadec-10-enoic acid
(2R)-2,3-Dihydroxypropanoic acid
(2S)-2-Aminopentanedioate
(2S)-2-Aminopentanedioic acid
(3R,4S,5R)-5-[(1R)-1-Carboxy-2,2-difluoro-1-(phosphonooxy)ethoxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylate
(R)-2,3-Dihydroxypropanoic acid
(R)-Glycerate
(R)-Glyceric acid
(S)-(+)-Glutamate
(S)-(+)-Glutamic acid
(S)-2-Aminopentanedioate
(S)-2-Aminopentanedioic acid
(S)-Glutamate
(S)-Glutamic acid
1,3,5(10)-Estratrien-3-ol-17-one
1-Amino-2-hydroxyethane
1-Aminopropane-1,3-dicarboxylate
1-Amino-propane-1,3-dicarboxylate
1-Aminopropane-1,3-dicarboxylic acid
1-Amino-propane-1,3-dicarboxylic acid
2 Acetamido 2 deoxy D glucose
2 Acetamido 2 deoxyglucose
2 Aminoethanol
2-Acetamido-2-deoxy-D-glucose
2-Acetamido-2-deoxyglucose
2-Amino-1-ethanol
2-Aminoethan-1-ol
2-Aminoethanol
2-Amino-ethanol
2-Aminoethyl alcohol
2-Aminoglutarate
2-Aminoglutaric acid
2-Aminopentanedioate
2-Aminopentanedioic acid
2-Ethanolamine
2-Hydroxyethanamine
2-Hydroxyethylamine
3a,7a,12a-Trihydroxy-5b-cholan-24-oylglycine
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oylglycine
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid-24-glycine
3alpha,7alpha,12alpha-Trihydroxy-N-(carboxymethyl)-5beta-cholan-24-amide
3-Hydroxy-1,3,5(10)-estratrien-17-one
3-Hydroxy-17-keto-estra-1,3,5-triene
3-Hydroxyestra-1,3,5(10)-trien-17-one
3-Hydroxyestra-1,3,5(10)-triene-17-one
3-Hydroxyoestra-1,3,5(10)-trien-17-one
3Α,7α,12α-trihydroxy-5β-cholan-24-oylglycine
3Α,7α,12α-trihydroxy-5β-cholanic acid-24-glycine
3Α,7α,12α-trihydroxy-N-(carboxymethyl)-5β-cholan-24-amide
a,b-Hydroxypropionate
a,b-Hydroxypropionic acid
a-Aminoglutarate
a-Aminoglutaric acid
Acetylglucosamine
Acide glutamique
Acido glutamico
ácido glutámico
Acidum glutamicum
Aciglut
Aethanolamin
a-Glutamate
a-Glutamic acid
alpha,beta-Hydroxypropionate
alpha,beta-Hydroxypropionic acid
alpha-Aminoglutarate
alpha-Aminoglutaric acid
alpha-Glutamate
alpha-Glutamic acid
Aluminum L glutamate
Aluminum L-glutamate
Aminoethanol
Aminoglutarate
Aminoglutaric acid
b-Aminoethanol
b-Aminoethyl alcohol
beta-Aminoethanol
beta-Aminoethyl alcohol
beta-Ethanolamine
beta-Hydroxyethylamine
b-Ethanolamine
b-Hydroxyethylamine
Cholylglycine
Colamine
D Glutamate
D1,3,5(10)-Estratrien-3-ol-17-one
D-2,3-Dihydroxypropanoic acid
D-GlcNAc
D-Glutamate
|
D-Glycerate
D-Glyceric acid
D-GroA
E
E 620
E620
E-620
Envision conditioner PDD 9020
Estrone, (+-)-isomer
Estrone, (8 alpha)-isomer
Estrone, (9 beta)-isomer
Estrovarin
ETA
Ethylolamine
FEMA NO. 3285
Follicular hormone
Folliculin
Glt
Glu
Glusate
Glut
Glutacid
Glutamate
Glutamate, potassium
GLUTAMIC ACID
Glutamic acid, (D)-isomer
Glutamicol
Glutamidex
Glutaminate
Glutaminic acid
Glutaminol
Glutaton
Glycerate
Glycine cholate
Glycinol
Glycocholate
Glycocholate sodium
Glycocholic acid, sodium salt
Glycoreductodehydrocholic acid
Glycylcholate
Glycylcholic acid
Hauck brand OF estrone
Hea
H-Glycinol
Hyrex brand OF estrone
INS NO.620
INS-620
Kestrone
L Glutamate
L Glutamic acid
L-(+)-Glutamate
L-(+)-Glutamic acid
L-a-Aminoglutarate
L-a-Aminoglutaric acid
L-alpha-Aminoglutarate
L-alpha-Aminoglutaric acid
L-Glu
L-Glu|L-glutamate|poly-L-glutamate
L-GLUTAMATE
L-Glutamate, aluminum
L-GLUTAMIC ACID
L-Glutaminate
L-Glutaminic acid
L-Glutaminsaeure
MEA
Monoaethanolamin
MONOETHANOLAMINE
N Acetyl D glucosamine
N-(Carboxymethyl)-3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-amide
N-(Carboxymethyl)-3α,7α,12α-trihydroxy-5β-cholan-24-amide
N-[(3a,5b,7a,12a)-3,7,12-Trihydroxy-24-oxocholan-24-yl]glycine
N-[(3alpha,5beta,7alpha,12alpha)-3,7,12-Trihydroxy-24-oxocholan-24-yl]glycine
N-[(3Α,5β,7α,12α)-3,7,12-trihydroxy-24-oxocholan-24-yl]glycine
N-Acetylchitosamine
N-Acetyl-D-glucosamine
N-Choloylglycine
N-Choloyl-glycine
NSC-143503
Oestrone
Olamine
Potassium glutamate
R-Glycerate
R-Glyceric acid
Unigen
Vortech brand OF estrone
Wehgen
Α,β-hydroxypropionate
Α,β-hydroxypropionic acid
Î’-aminoethanol
Î’-aminoethyl alcohol
Î’-ethanolamine
Î’-hydroxyethylamine
|
|
21 |
|
Passionflower |
|
Phase 4 |
|
|
|
22 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
23 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
24 |
|
Narcotic Antagonists |
|
Phase 4 |
|
|
|
25 |
|
Sympatholytics |
|
Phase 4 |
|
|
|
26 |
|
Narcotics |
|
Phase 4 |
|
|
|
27 |
|
Nicotinic Agonists |
|
Phase 4 |
|
|
|
28 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
29 |
|
Opiate Alkaloids |
|
Phase 4 |
|
|
|
30 |
|
Antidepressive Agents |
|
Phase 4 |
|
|
|
31 |
|
Serotonin and Noradrenaline Reuptake Inhibitors |
|
Phase 4 |
|
|
|
32 |
|
Antipsychotic Agents |
|
Phase 4 |
|
|
|
33 |
|
Pharmaceutical Solutions |
|
Phase 4 |
|
|
|
34 |
|
Detox adjuvant |
|
Phase 4 |
|
|
|
35 |
|
Adjuvants, Immunologic |
|
Phase 4 |
|
|
|
36 |
|
Immunologic Factors |
|
Phase 4 |
|
|
|
37 |
|
Dopamine Antagonists |
|
Phase 4 |
|
|
|
38 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
39 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
40 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
41 |
|
phenazepam |
|
Phase 4 |
|
|
40113 |
42 |
|
Antidiarrheals |
|
Phase 4 |
|
|
|
43 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
44 |
|
Haloperidol decanoate |
|
Phase 4 |
|
|
52919 |
Synonyms:
4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl decanoic acid
HALDOL
Haldol dec
Halomonth
HALOPERIDOL DECANOATE
|
HALOPERIDOL decanoic acid
R-13672
R-13672R-13672HAloperidol decanoate
R-13672R-13672HAloperidol decanoic acid
|
|
45 |
|
Immunoglobulins |
|
Phase 4 |
|
|
|
46 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
47 |
|
Antithyroid Agents |
|
Phase 4 |
|
|
|
48 |
|
Antibodies |
|
Phase 4 |
|
|
|
49 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
50 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 139)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Efficacy and Safety of the Administration of the Passiflora Extract for Benzodiazepine Withdrawal in Institutionalized Older Adults: Clinical Trial Phase III |
Unknown status |
NCT03780595 |
Phase 4 |
Passiflora incarnata;Control |
2 |
Prospective Assessment of Valproate on Ethanol Withdrawal |
Unknown status |
NCT03235531 |
Phase 4 |
Valproate;Lorazepam |
3 |
A Behavioral Assessment of Electronic Cigarettes in Reducing Cue- and Withdrawal-induced Craving in Daily Dependent Smokers |
Completed |
NCT02108626 |
Phase 4 |
Nicotine;Placebo |
4 |
A Prospective Randomized Controlled Open Label Trial of Symptom-triggered Benzodiazepine Versus Fixed-dose Gabapentin for Alcohol Withdrawal Syndrome |
Completed |
NCT03012815 |
Phase 4 |
Gabapentin;Benzodiazepines;Divalproex Sodium |
5 |
Treatment of Polydrug-Using Opiate Dependents During Withdrawal |
Completed |
NCT00367874 |
Phase 4 |
Buprenorphine;Valproate |
6 |
A Comparative Study of the Efficacy of Venlafaxine and Naltrexone for Relapse Prevention in Patients With Opioid Use Disorder Attributed to Tramadol |
Completed |
NCT05569031 |
Phase 4 |
Venlafaxine;Lofexidine |
7 |
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome |
Completed |
NCT04298853 |
Phase 4 |
Morphine PRN;Morphine scheduled |
8 |
The Gamma Hydroxybutyric Acid in Alcohol-dependence Treatment Efficacy (GATE) I Trial: a Comparative Study Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome |
Completed |
NCT02090504 |
Phase 4 |
Sodium Oxybate (SMO);Oxazepam |
9 |
Acute Drug Withdrawal in a General Medical Setting |
Completed |
NCT00249366 |
Phase 4 |
Lorazepam (drug);Lorazepam |
10 |
Nicotine Replacement Therapy in the Intensive Care Unit: a Randomized, Controlled Pilot Study |
Completed |
NCT01362959 |
Phase 4 |
Transdermal nicotine patch |
11 |
Randomized Clinical Trial of Pregabalin for Opioid Withdrawal Syndrome |
Completed |
NCT03017430 |
Phase 4 |
Pregabalin;Clonidine;Doxylamin;Ketorolac, Loperamide, Metoclopramide, Nefazolin and Phenazepam (benzodiazepine) |
12 |
Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán |
Completed |
NCT03877120 |
Phase 4 |
Dexmedetomidine 0.004 MG/ML;Diazepam Injectable Solution |
13 |
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine |
Completed |
NCT03698331 |
Phase 4 |
Valbenazine;Placebo oral capsule |
14 |
Varenicline OTC Trial on Efficacy and Safety |
Completed |
NCT03557294 |
Phase 4 |
1.0mg Varenicline b.i.d.;0.5mg Varenicline b.i.d.;0.0mg placebo Varenicline b.i.d. |
15 |
A Double-blind Randomised Controlled Clinical Trial of Lofexidine Versus Diazepam in the Management of the Opioid Withdrawal Syndrome During Inpatient Detoxification in Singapore |
Completed |
NCT01675648 |
Phase 4 |
Lofexidine;Diazepam;Placebo for Lofexidine;Placebo for Diazepam |
16 |
Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal Syndrome in the ICU: a Randomised Controlled Study |
Completed |
NCT02496650 |
Phase 4 |
Dexmedetomidine |
17 |
Clinical Study on the Effect of Routine Treatment and Intensive Treatment on the Regulation of Graves' Disease and the Cumulative Recurrence Two Years After Drug Withdrawal |
Recruiting |
NCT05461820 |
Phase 4 |
Methimazole |
18 |
Assessment of NADA Acupuncture for Treatment of Withdrawal Symptoms During Gradual Opioid Withdrawal in Chronic Pain Patients |
Not yet recruiting |
NCT03397212 |
Phase 4 |
|
19 |
Evaluation of Pregabalin's Abuse Liability and Its Effects on Benzodiazepine Withdrawal Symptoms in Inpatients Undergoing Medically Assisted Benzodiazepine Withdrawal |
Terminated |
NCT02423018 |
Phase 4 |
Pregabalin;Placebo |
20 |
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Dexmedetomidine (Precedex®), With Lorazepam Rescue, for the Management of Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD) |
Terminated |
NCT01362205 |
Phase 4 |
Dexmedetomidine;Placebos |
21 |
A Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Phenobarbital and Ketamine Adjunctive Therapies in the Treatment of Alcohol Withdrawal Syndrome |
Withdrawn |
NCT03788889 |
Phase 4 |
Ketamine;Phenobarbital;Lorazepam;Placebo A;Placebo B |
22 |
Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy, Safety, and Dose-Response Study of Lofexidine for Treatment of Opioid Withdrawal (Days 1-7) Followed by Open-Label, Variable Dose Lofexidine Treatment (Days 8-14) |
Completed |
NCT01863186 |
Phase 3 |
Lofexidine HCl;Placebo;Open Label Lofexidine HCL |
23 |
Multicenter Randomized Placebo Controlled Trial Assessing the Efficacy of Oral Adjuvant Magnesium Supplementation in the Treatment of Alcohol Withdrawal Syndrome |
Completed |
NCT03033823 |
Phase 3 |
Magnesium;Placebo Oral Tablet |
24 |
Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome [Sicherheit Und Wirksamkeit Von Levetiracetam (Keppra) für Die Behandlung Des stationären Alkoholentzugsyndroms] |
Completed |
NCT00146471 |
Phase 3 |
Levetiracetam;Placebo |
25 |
Buprenorphine/Naloxone Versus Clonidine For Out-patient Opiate Detoxification |
Completed |
NCT00032968 |
Phase 3 |
Buprenorphine/naloxone |
26 |
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification |
Completed |
NCT00032955 |
Phase 3 |
Buprenorphine/naloxone |
27 |
Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal |
Completed |
NCT00980044 |
Phase 2, Phase 3 |
Tramadol;Placebo |
28 |
Pharmacogenetics, Emotional Reactivity and Smoking Cessation: Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal |
Completed |
NCT00664404 |
Phase 3 |
|
29 |
A Randomized, Double-Blind, Multiple-Dose, Parallel Group Study to Evaluate the Potential of Withdrawal Effects Following Administration of Oxycodone/Naltrexone Capsules and Oxycodone in Methadone-Maintained Opioid-Dependent Subjects |
Completed |
NCT02391571 |
Phase 3 |
Oxycodone/Naltrexone Capsules;Oxycodone;Placebo |
30 |
Comparison of a Fixed-Schedule Therapy Versus a Symptom-Triggered Therapy for Alcohol Withdrawal Syndrome in Medical Out-Patients |
Completed |
NCT00136617 |
Phase 3 |
chlordiazepoxide |
31 |
A Phase 3, Open-Label, Safety Study of Lofexidine |
Completed |
NCT02363998 |
Phase 3 |
Lofexidine |
32 |
The Efficacy of N-acetylcysteine Versus Placebo for the Treatment of Metamphetamine Withdrawal Symptoms |
Completed |
NCT04405193 |
Phase 2, Phase 3 |
N-acetyl cysteine;Placebo |
33 |
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations: Conceptual Model Assessments (CMA) Sub-study |
Recruiting |
NCT03911466 |
Phase 3 |
Buprenorphine Injection;Buprenorphine Sublingual Product |
34 |
Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): a Pragmatic Randomized Trial Comparing Extended-release and Daily Buprenorphine Formulations |
Recruiting |
NCT03918850 |
Phase 3 |
Buprenorphine Injection;Buprenorphine Sublingual Product |
35 |
Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS) |
Recruiting |
NCT04214834 |
Phase 3 |
Morphine;Methadone |
36 |
NIDA CTN Protocol 0080: Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMs): Infant Neurodevelopmental Outcomes (INO) Sub-study |
Recruiting |
NCT03911739 |
Phase 3 |
Buprenorphine Injection;Buprenorphine Sublingual Product |
37 |
Prospective Randomized Blinded Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS) |
Not yet recruiting |
NCT04455802 |
Phase 3 |
Buprenorphine or Placebo;Morphine or Placebo |
38 |
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD: A Pilot Double-blind, Randomized Clinical Trial |
Not yet recruiting |
NCT04759703 |
Phase 2, Phase 3 |
Pramipexole;Placebo |
39 |
Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal in People With Chronic Pain Undergoing Voluntary Opioid Tapering: a Pilot Study |
Not yet recruiting |
NCT04939623 |
Phase 2, Phase 3 |
Probenecid |
40 |
Prospective, Randomized, Open Label Controlled Trial To Evaluate The Safety And Efficacy Of Dexmedetomidine Use Beyond 24 Hours Compared With Midazolam In Children Admitted To Pediatric Intensive Care Unit (PICU) at KASCH-MNGHA. |
Not yet recruiting |
NCT05485519 |
Phase 3 |
Dexmedetomidine;Midazolam |
41 |
Preventing Alcohol Withdrawal Syndrome With Oral Baclofen: A Randomized, Placebo Controlled Trial |
Terminated |
NCT02052440 |
Phase 3 |
Baclofen;Placebo |
42 |
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study |
Unknown status |
NCT02249026 |
Phase 1, Phase 2 |
BZDs + opiate exposure treated with BPN;Opiates exposure treated with BPN |
43 |
ASSESSMENT OF THE SAFETY AND BENEFIT OF PROSPECTIVE IMMUNOSUPPRESSIVE DRUG WITHDRAWAL IN LIVER TRANSPLANTATION AND PREDICTION OF OPERATIONAL TOLERANCE |
Unknown status |
NCT00647283 |
Phase 2 |
|
44 |
A Phase 1b/2 Randomized, Double-Blind, Placebo-Controlled, Ascending- Dose Study of BXCL501 to Treat Symptoms of Acute Opioid Withdrawal in Patients With Opioid Use Disorder Who Are Physically Dependent on Opioids |
Unknown status |
NCT04470050 |
Phase 1, Phase 2 |
Sublingual film containing Dexmedetomidine (BXCL501);Placebo film for BXCL501 |
45 |
A Randomized Comparison of Sublingual Buprenorphine to Morphine Sulfate in the Treatment of Neonatal Abstinence Syndrome (NAS) |
Completed |
NCT01708707 |
Phase 2 |
Buprenorphine;Morphine Sulfate |
46 |
Effects of Dynorphin 1-13 on Heroin Addiction |
Completed |
NCT00000244 |
Phase 2 |
Dynorphin 1 - 13 |
47 |
Modeled Dose Exposure of Sublingual Buprenorphine in the Neonatal Opioid Abstinence Syndrome |
Completed |
NCT03608696 |
Phase 1, Phase 2 |
Buprenorphine |
48 |
An Open Label Trial of Lithium for the Management of Cannabis Withdrawal |
Completed |
NCT00114439 |
Phase 2 |
Lithium carbonate |
49 |
The Effect of Melatonin Upon Post-Acute Withdrawal Among Males in a Residential Treatment Program: A Randomized, Double Blind, Placebo, Controlled Trial |
Completed |
NCT02431728 |
Phase 1, Phase 2 |
|
50 |
Gabapentin Vs. Lorazepam in Alcohol Withdrawal |
Completed |
NCT00229125 |
Phase 2 |
Gabapentin;Lorazepam |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
Carbamazepine
Clonidine
CLONIDINE HCL PWDR
Clonidine Hydrochloride
Haloperidol
haloperidol decanoate
Haloperidol lactate
|
Hydroxyzine
Hydroxyzine Hydrochloride
Hydroxyzine Pamoate
Lorazepam
Perphenazine
Procaine
Procaine hydrochloride
|
|